期刊文献+

他汀类非调脂作用在稳定急性冠脉综合征病变斑块的机制 被引量:5

Mechanism of Statins’ Noncholesterol-lowering Effects on Stabilizing Atherosclerotic Plaques of Acute Coronary Syndrome
下载PDF
导出
摘要 急性冠脉综合征主要由斑块破裂、血栓形成所致。他汀类属羟甲基戊二酸辅酶A还原酶抑制剂,除调脂作用之外尚有非调脂作用,即多向性效应。它包括抗炎作用,逆转内皮功能失调,降低动脉粥样硬化斑块的脆性,抗血小板凝聚和减少血栓形成等效应,在稳定急性冠脉综合征病变斑块方面发挥着重要作用。 Acute coronary syndrome is mainly cattsed by rupttlre of atherosclerotic plaques which causing thrombotic formation. Hydroxymethylglutaryl coenzyme A reductase inhibitors, statins,are not only lowered serum hypercholesterolemia,but also have noncholesterol-lowering effects or pleiotropic actions. It involves in anti-inflammatory effects, reversion of endothelial dysfunction, reducing brittleness of atherosclerotic plaques, antl-thrombotic effects and redtlce thrombotic formation. They exert an importance of stabilizing atherosclerotic plaque of acute coronary syndrome.
出处 《心血管病学进展》 CAS 2005年第B08期1-3,共3页 Advances in Cardiovascular Diseases
关键词 他汀类 急性冠脉综合征 非调脂作用或多向性效应 Statins Acute coronary syndrome Noncholesterol-loweriog effects or plelotropic actions
  • 相关文献

参考文献28

  • 1Scandinavian Simvastatin Survival Study Group. Randomised trial of cholesterol lowering in 4.444 patients with coronary heart disease:The Scandinavian Simvastatin Survival Study (4S) [J]. Lancet, 1994.344 : 1383-1389.
  • 2Vaughan CJ,Gotto AM, Basson CT. The evolving role of statins in the management of atherosclerosis[J ]. J A m Coll Cardiol, 2000,35 : 1-10.
  • 3Schwartz GG. Olsson AG. Ezekowitz M D.et al. Myocardial Ischaemia Reduction with Aggressive Cholesterol Lowering (M[RACL) Study investigators. Effects of atorvastatin on early recurrent ischaemic events in acute coronary syndromes:the MIRACI, study : a randomized controlled trial[J ]. JAMA ,2001.285 ( 13 ) : 1711 -1718.
  • 4Athyros VG. Papageorgiou AA, Mercouris BR. et al. Treatment with atorvastatin to the National Cholesterol Educatlonal Program Goals versus usual care in secondary coronary heart disease prevention. The Greek Atorvastatin and Coronary-heart-disease Evaluation. (GREACE) Study[J]. Curr Med Res Opin.2002,18(4) :220-228.
  • 5Libby P. Ridker PM. Maseri A. Inflammation and atherosclerosis [ J ]. Circulation,2002,105 : 1135-1143.
  • 6Rezaie-Majd A, Maca T,Bucek RA ,et al. Simvastatin reduces expression of cytokines interleukin-5 ,interleukin-8, and monocyte chemoattraetant protein-1 in circulating monocytes from hypercholesterolemic patients[ J ] . Arierioscler Thromb Vase Biol,2002.22: 1194-1199.
  • 7Lindmark E, Diderhom E. Wallentin L, et al. Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease[J ]. JAMA ,2001 ,286:2107-2013.
  • 8Morrow DA ,Rifai N,Antman EM, et al. C-reactive protein is a potent predictor of mortality independently of and in combination with troponin T in acute coronary syndromes: a TIMI ⅡA substudy. Thromholysis in Myocardial Infarction[J].J Am Coll Cardiol, 1998,31 : 1460-1465.
  • 9Seljeflot I. Tonstad S. Hjerman I, et al. Reduced expression of endothelial cell markers after one year treatment with simvastatin and atorvastatin in patients with coronary heart disease [ J ], Atherosclerosis .2002,162 ( 1 ) : 179-185.
  • 10Koh KK,Son JW,Ahn JY,et al. Non-lipid effects of statin on hypercholesterolemic patients established to have coronary, artery disease who remained hypercholesterolemic while eating a step- Ⅱ diet [ J ]. Coron Artery Dis, 2001, 12(4) :305-311.

二级参考文献15

  • 1Schonbeck U, Sukhova GK, Shimizu K, et al. Inhibition of CD40 signaling limits evolution of established atherosclerosis in mice. Proc Nail Acad Sci USA, 2000, 97: 7458-7463.
  • 2Lutgens E, Cleutjens KBJM, Heeneman S, et al. Both early and delayed anti-CD40L antibody treatment induces a stable plaque phenotype. Proc Nail Aced Sci. USA, 2000, 97: 7464-7469.
  • 3Kai H,Ikeda H, Yasukawa H, et al. Perpherial blood levels of matrix metalloproteinase-2 and 9 are evelated In patients with acute coronary sndrome. J Am Coll Cardiol , 1998,32:368-372.
  • 4Taku T, Toshio H, Hatsuyo K, et al. Cerivastatin, a HMG-CoA Reductase Inhibitor, Improves Endothelial Function In Elderly Diabetics winthin 3 days. Circulation, 2001,104:376-379.
  • 5Ross R. Atherosclerosis-An inflammatory disease. N Eng J Med, 1999,340: 115-126.
  • 6Goran K Hansson. Immune Mechanism In Atherosclerosis Arteroscler Thromb Vasc Biol . 2001,21:1876-1890.
  • 7Koefig W. Inflammation and coronary heart disease:an overview Cardiol Rev, 2001,9:31-35.
  • 8Mach F, Schonbeck U, Bonnefoy JY, et al. Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40: induction of collagenase, stromelysin, and tissue factor. Circulation, 1997,96:396-399.
  • 9Brown DL, Hibbs MS, Kearney M, et al. Identification 92 kDa gelatinase in human coronary atherosclerotic lesions: association of active enzyme synthesis with unstable angina. Circulation , 1995, 91: 2125-2131.
  • 10Chalmers J, WHO-ISH Hypertension Guidelines Committee. 1999 World Health Organization-International Society of Hypertension Guidelines for Management of Hypertension. J Hypertens, 1999,17:151-183.

共引文献99

同被引文献62

引证文献5

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部